Perirenal fat as a potential marker and therapeutic target for metabolic syndrome: insights from a multicenter randomized controlled trial

BackgroundMetabolic syndrome (MetS) represents a constellation of metabolic abnormalities. Perirenal fat is a type of visceral fat surrounding the kidneys and possesses distinct anatomical and physiological features. This study aims to investigate the association between perirenal fat volume (PrFV)...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Hua, Meng-Huan Li, Yu-Xuan Lou, Ke-Rui Zhang, Jia-Ming Yang, Yan-Hui Sheng, Yu-Qing Zhang, Chuan-li Cheng, Chao Zou, Ting-ting Wu, Xiang-Qing Kong, Wei Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1557701/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundMetabolic syndrome (MetS) represents a constellation of metabolic abnormalities. Perirenal fat is a type of visceral fat surrounding the kidneys and possesses distinct anatomical and physiological features. This study aims to investigate the association between perirenal fat volume (PrFV) and MetS in Chinese adults.MethodsWe conducted a post-hoc cross-sectional analysis within a multicenter, randomized clinical trial. Demographic information, anthropometric data and laboratory tests were obtained from the electronic data capture system. PrFV was assessed and measured by ultrasonography. Subcutaneous and visceral fat volume were quantified by abdominal MRI. Individuals were categorized according to PrFV tertiles, and Spearman correlation analysis was performed to investigate the correlation between PrFV and metabolic profiles. Adjusted multivariable regression models were employed to investigate the relationship of PrFV with MetS. The receiver operating characteristic curve was used to identify the value of PrFV for predicting MetS.ResultsAmong 100 enrolled subjects, the median age was 50.0 (40.0-60.0) years, and 75% were male. Spearman correlation analysis revealed significant positive correlations between PrFV and total cholesterol (r = 0.24, P = 0.02), triglycerides (r = 0.32, P = 0.001), LDL-C (r = 0.21, P = 0.04), diastolic blood pressure (r = 0.24, P = 0.02), BMI (r = 0.39, P < 0.001), waist circumference (r = 0.39, P < 0.001), and uric acid (r = 0.40, P < 0.001). In the fully-adjusted multivariable regression model, individuals in the highest tertile of PrFV exhibited a higher risk of MetS (Odds ratio = 4.48, 95% Confidence interval: 1.25-17.6). The area under the curve (AUC) of PrFV for predicting MetS was higher than subcutaneous and visceral fat volume.ConclusionIncreased PrFV was positively associated with a higher risk of MetS in Chinese adults. Perirenal fat may serve as a surrogate marker and potential therapeutic target for MetS.Clinical trial registrationhttps://clinicaltrials.gov/, identifier NCT 05049096.
ISSN:1664-2392